SCHEMBL6174747

SCHEMBL6174747

CC1(Cc2ccnc(NS(N)(=O)=O)c2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 19/20 0.57
ITGAL P20701 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174982 0.90 IGF1R (0.56) IGF1RITGAL
SCHEMBL6173379 0.88 IGF1R (0.54) IGF1R
SCHEMBL6172752 0.88 IGF1R (0.54) IGF1R
SCHEMBL6173826 0.87 IGF1R (0.53) IGF1R
SCHEMBL6175526 0.87 IGF1R (0.42) IGF1RITGAL
SCHEMBL6177798 0.86 IGF1R (0.57) IGF1R
SCHEMBL6173795 0.86 IGF1R (0.67) IGF1RITGAL
SCHEMBL6174740 0.83 IGF1R (0.53) IGF1RITGAL
SCHEMBL6174040 0.83 IGF1R (0.63) IGF1R
SCHEMBL6176651 0.82 IGF1R (0.64) IGF1RITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed